Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026)

Aytu Biopharma (AYTU) has 14 years of Asset Utilization Ratio data on file, last reported at 0.48 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.48, down 11.56% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.48 (down 11.56% YoY), and the FY2025 annual result was 0.55, up 7.0% from the prior year.
• Asset Utilization Ratio fell to 0.48 in Q1 2026 per AYTU's latest filing, from 0.51 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.76 in Q2 2023 and troughed at 0.47 in Q1 2022.
• A 5-year average of 0.6 and a median of 0.55 in 2025 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio soared 137.29% in 2022, then plunged 30.28% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.72 in 2022, then retreated by 5.92% to 0.68 in 2023, then dropped by 22.36% to 0.53 in 2024, then declined by 4.17% to 0.51 in 2025, then decreased by 4.5% to 0.48 in 2026.
• Business Quant data shows AYTU's Asset Utilization Ratio at 0.48 in Q1 2026, 0.51 in Q4 2025, and 0.51 in Q3 2025.